French Study Tracks 28 Million People, Finds Lower Death Rates Among Vaccinated
Finn's Take· TL;DR- French study of 28.7 million people found vaccinated individuals had 25% lower mortality over nearly four years compared to unvaccinated.
- Vaccinated group showed 74% lower COVID-19 death risk in hospitals and lower cancer diagnoses, despite being older with more health conditions.
- Researchers emphasize findings counter vaccine misinformation while acknowledging demographic and social factors beyond vaccination may partially explain mortality differences.
Massive Study Reveals Striking Mortality Differences
A groundbreaking study examining nearly half of France's population has delivered compelling evidence about COVID-19 vaccine safety and effectiveness. Researchers tracked 28.7 million people using France's comprehensive health data system, where every resident has a number against which their vaccination status and medical outcomes are recorded . The scope is unprecedented—rarely do scientists have access to such complete national health records.
The results showed that 0.4 percent of the vaccinated cohort had died after almost four years had passed, but this rose to 0.6 percent among the unvaccinated . While these numbers might seem small, they represent thousands of lives across a population this size. The team concluded that mRNA vaccination against COVID-19 was associated with 25 percent lower mortality from any cause .
In the first six months after vaccination, the gap was even larger, with deaths among the vaccinated 29 percent lower than the unvaccinated . This finding challenges persistent claims about vaccine-related deaths that have circulated on social media platforms.
Beyond COVID Protection
The study revealed benefits extending far beyond COVID-19 protection itself. Those who had been vaccinated with an mRNA COVID-19 vaccine were found to have a 74 percent lower risk of death from COVID-19 in hospital . Yet the mortality advantage persisted across all causes of death, including things like car accidents and natural disasters, which are highly unlikely to be affected by vaccination status .
This broader pattern suggests complex factors at play. Vaccinated individuals were older than unvaccinated individuals, more frequently women and had more cardiometabolic comorbidities —characteristics that would typically predict higher, not lower, death rates. The fact that vaccinated people still showed better outcomes despite these risk factors makes the findings more remarkable.
Vaccinated adults were about 15 percent less likely to be diagnosed with cancer than those who were unvaccinated , adding another dimension to the health differences between groups.
Addressing Vaccine Skepticism
"We can say with a high degree of confidence that there is no increase in the risk of mortality after a Covid vaccine," said Mahmoud Zureik, who supervised the study . This direct statement counters years of misinformation campaigns. "This study helps to put an end to the misinformation spread about mRNA vaccines," the study's lead author told Le Monde. "Providing data on the absence of long-term risks helps strengthen confidence in these vaccines, which will be developed for other viruses and diseases."
The research addresses a critical gap in vaccine safety monitoring. In countries where individuals need to agree to provide data on their vaccination status and subsequent outcomes, large sample sizes are expensive. Some studies have tried to get around this by using regional statistics, which show death rates were higher where vaccinations were least common, but this approach can't prove the deaths were among the unvaccinated .
Understanding the Complexity
The researchers acknowledge their findings don't tell the complete story. The reasons why people were not vaccinated during the study period are not known, but it's possible that some of them were swayed by false claims about the vaccine's dangers. The authors tactfully refer to this and other unknowns, such as education, as residual confounding factors .
While the researchers are confident the vaccines did not trigger increased mortality, they stress that the study cannot, by itself, prove that vaccination caused an overall reduction in deaths. The gap between the vaccinated and unvaccinated groups may stem from the protective effects of the vaccines but could also reflect demographic and social differences such as age or socio-economic background .
This massive French dataset provides the most comprehensive long-term safety assessment of mRNA vaccines to date. As new vaccines are developed for other diseases, this research methodology could become the gold standard for post-market surveillance, offering populations the confidence that comes from real-world evidence at unprecedented scale.